Loading stock data…
EHC
$100.90-0.43 (-0.42%)
Market ClosedLast close Jun 29
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Encompass Health Corporation in the Healthcare sector is trading at $100.90 with a market capitalization of $9.9B. Wall Street consensus targets $140.50 (12 analysts), implying a +39.2% move over the next 12 months. The stock is currently 21% below its 52-week high of $127.99, remaining 7.0% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +39.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.59B↑ | $1.54B↑ | $1.48B↑ | $1.46B↑ | $1.46B |
| Gross Profit | $1.52B↑ | $1.48B↑ | $1.41B↑ | $626.90M↓ | $630.90M |
| Operating Income | $301.60M↑ | $283.40M↑ | $243.60M↓ | $259.10M↓ | $267.00M |
| Net Income | $194.50M↑ | $146.10M↑ | $126.50M↓ | $142.10M↓ | $151.50M |
Peer Comparison
JNJUNHPFE
Fundamentals
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.93B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.73%
ROE
Elite ROE. Management converts capital into profit efficiently.
24.16%
Volume
Today's trading volume
693,178
Recent News
Can Encompass Health's Expansion Strategy Drive Its Next Growth Phase?
EHC is accelerating hospital and bed expansions to boost capacity, with execution now key as stronger results support higher 2026 EPS guidance.
How HCA Stock's Quiet Compounding Changes The Growth Story
With shares lagging and revenue growth slowing, the market seems to be missing the powerful engine driving HCA's per-share earnings higher.
DaVita Expands Specialized Care Beyond Acute Settings Through IKC
DVA is expanding kidney care beyond hospitals with IKC, digital tools and AI to improve coordination, lower costs and support patients.
DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026?
One dominates kidney care with global reach, while the other leads in rehab with faster growth and higher margins. Which business model stands out for 2026?
Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit
Healthcare added 35,200 jobs in May, supporting growth opportunities for healthcare stocks that are positioned for the underlying trends